NEW YORK (GenomeWeb) – This year, Invitae has already acquired four companies, with the latest purchase of CombiMatrix and Good Start Genetics this week enabling its entry into reproductive health testing. But this may be just the start of the company's M&A activities.

The company is at a point where "it's wise to consider acquisitions that can positively contribute to cash flow within a two-to-three-quarter period of time," Invitae CEO Sean George told investors and analysts during a call to discuss the company's latest acquisitions.